Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan;26(1):28-33.
doi: 10.1097/MOH.0000000000000476.

The role of CXCR2 in acute inflammatory responses and its antagonists as anti-inflammatory therapeutics

Xiaoyu Zhang  1   2 , Rongxia Guo  3 , Hiroto Kambara  1   2 , Fengxia Ma  3 , Hongbo R Luo  1   2
Affiliations

The role of CXCR2 in acute inflammatory responses and its antagonists as anti-inflammatory therapeutics

Xiaoyu Zhang et al. Curr Opin Hematol. 2019 Jan.

Abstract

Purpose of review: CXCR2 is key stimulant of immune cell migration and recruitment, especially of neutrophils. Alleviating excessive neutrophil accumulation and infiltration could prevent prolonged tissue damage in inflammatory disorders. This review focuses on recent advances in our understanding of the role of CXCR2 in regulating neutrophil migration and the use of CXCR2 antagonists for therapeutic benefit in inflammatory disorders.

Recent findings: Recent studies have provided new insights into how CXCR2 signaling regulates hematopoietic cell mobilization and function in both health and disease. We also summarize several CXCR2 regulatory mechanisms during infection and inflammation such as via Wip1, T-bet, P-selectin glycoprotein ligand-1, granulocyte-colony-stimulating factor, and microbiome. Moreover, we provide an update of studies investigating CXCR2 blockade in the laboratory and in clinical trials.

Summary: Neutrophil homeostasis, migration, and recruitment must be precisely regulated. The CXCR2 signaling pathway is a potential target for modifying neutrophil dynamics in inflammatory disorders. We discuss the recent clinical use of CXCR2 antagonists for controlling inflammation.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

There are no conflicts of interest.

References

    1. Manzo A, Caporali R, Montecucco C, Pitzalis C. Role of chemokines and chemokine receptors in regulating specific leukocyte trafficking in the immune/inflammatory response. Clin Exp Rheumatol 2003; 21:501–508. - PubMed
    1. Wu Y, Wang S, Farooq SM, et al. A chemokine receptor CXCR2 macromolecular complex regulates neutrophil functions in inflammatory diseases. J Biol Chem 2012; 287:5744–5755. - PMC - PubMed
    1. Raghuwanshi SK, Su Y, Singh V, et al. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions. J Immunol 2012; 189:2824–2832. - PMC - PubMed
    1. Thelen M, Munoz LM, Rodriguez-Frade JM, Mellado M. Chemokine receptor oligomerization: functional considerations. Curr Opin Pharmacol 2010; 10:38–43. - PubMed

    1. Del Prete A, Martinez-Munoz L, Mazzon C, et al. The atypical receptor CCRL2 is required for CXCR2-dependent neutrophil recruitment and tissue damage. Blood 2017; 130:1223–1234.

      The article revealed that CCRL2 could constitutively form homodimers and heterodimers with CXCR2. CCRL2/CXCR2 heterodimerization regulated membrane expression and promoted CXCR2 function, providing a novel mechanism for CXCR2 functional regulation.

Publication types

MeSH terms